Acute and chronic kidney function decline in patients receiving BRAF/MEK inhibitors for melanoma
Nephrol Dial Transplant
.
2024 Feb 22:gfae049.
doi: 10.1093/ndt/gfae049.
Online ahead of print.
Authors
Kavita Mistry
1
2
,
Sophia Zhao
3
,
Ian Strohbehn
4
,
Qiyu Wang
4
,
Paul Hanna
4
5
,
Samuel Strohbehn
4
,
Nurit Katz-Agranov
4
,
Ryan J Sullivan
6
,
Meghan E Sise
4
Affiliations
1
Department of Medicine, Division of Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
2
Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
3
Analytica Now LLC, Brookline, MA, USA.
4
Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, MA, USA.
5
Department of Medicine, Division of Nephrology, Medical College of Wisconsin, Milwaukee, WI, USA.
6
Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA, USA.
PMID:
38389257
DOI:
10.1093/ndt/gfae049
No abstract available